Regeneron Pharmaceuticals Inc. buy piccolo90
Summary
This prediction ended on 04.10.17 with a price of €409.02. The BUY prediction by piccolo90 finished with a performance of 18.35%. piccolo90 has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Regeneron Pharmaceuticals Inc. | -0.507% | -0.507% | 30.615% | 118.243% |
iShares Core DAX® | -0.552% | 3.281% | 15.052% | 17.017% |
iShares Nasdaq 100 | -1.415% | 4.535% | 26.243% | 54.337% |
iShares Nikkei 225® | -0.877% | -1.739% | 4.897% | 4.751% |
iShares S&P 500 | -0.415% | 3.239% | 23.253% | 46.758% |
Comments by piccolo90 for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
piccolo90 stimmt der fundamentalen Bewertung mit dem Ergebnis 'unterbewertet' zu
piccolo90 stimmt am 04.04.2017 der fundamentalen Bewertung mit dem Ergebnis unterbewertet zu.
Stopped prediction by piccolo90 for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
02.10.18
10.07.19
10.07.19
Regeneron Pharmaceuticals Inc.
13.05.18
02.08.18
02.08.18
Regeneron Pharmaceuticals Inc.
21.12.17
06.03.18
06.03.18
Regeneron Pharmaceuticals Inc.
03.05.16
03.11.16
03.11.16
Regeneron Pharmaceuticals Inc.
28.07.15
04.08.15
04.08.15